1. Home
  2. Vol 8, No 4
  3. Qomariyah

Cost Of Illnes As A Basic For Advocacy Efforts to Prevent An Increase In The Prevalence of Type 2 Diabetes Mellitus

Nurul Laily Qomariyah(1*), Thinni Nurul Rochmah(2), Rizka Rosa DM(3)
(1) Universitas Airlangga Surabaya (Unair)
(2) 1) Departement of Health Policy and Administration Faculty of Public Health Universitas Airlangga; 2) The Airlangga Centre for Health Policy Research Group, Surabaya, Indonesia
(3) Department of Health Policy and Administration, Faculty of Public Health Science, Airlangga University, Surabaya, Indonesia
(*) Corresponding Author
DOI : 10.30604/jika.v8i4.2201

Abstract

Diabetes mellitus is a chronic disease that requires continuous treatment. This can result in an economic burden on sufferers. One method that can be used in analyzing the economic burden due to a disease is the Cost of Illness method by calculating the direct and indirect costs of sufferers and program costs that have been incurred by the government. The purpose of this study was to analyze the Cost of Illness in type 2 diabetes mellitus patients. This research was a quantitative descriptive cross-sectional approach. The sampling technique used multistage random sampling and obtained a sample size of 144 type 2 diabetes mellitus patients from hospitals and health centers in Bulungan Regency, North Kalimantan. The results of the analysis of the Cost of Illness for type 2 diabetes mellitus patients in Bulungan Regency amounted to Rp.7,350,237 per patient each year. The results of the calculation of the Cost of Illness for type 2 diabetes mellitus patients can be used to advocate that promotive and preventive programs are the main focus of disease control, and promote a social security system to offset the direct costs of individuals, so that the entire population can be protected from the high Cost of Illness.

 

Keywords: Cost of illness, Diabetes Mellitus, promotive, preventive

Keywords


Cost of illness, Diabetes Mellitus, promotive, preventive

References


Abror, N. A., Andayani, T. M., & Sulistiawaty, E. (2019). Analisis Biaya Penyakit Diabetes Melitus Sebagai Pertimbangan Perencanaan Pembiayaan Kesehatan: Cost Analysis of Diabetes Mellitus Disease as Considerations In Health Funding Planning. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 5(1), 73 - 83. https://doi.org/10.22487/j24428744.2019.v5.i1.12071

Afroz, A., Alramadan, M. J., Hossain, M. N., Romero, L., Alam, K., Magliano, D. J., & Billah, B. (2018). Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC health services research, 18(1), 1-10. https://doi.org/10.1186/s12913-018-3772-8

Akari, S., Mateti, U. V., & Kunduru, B. R. (2013). Health-care cost of diabetes in South India: A cost of illness study. Journal of research in pharmacy practice, 2(3), 114–117. https://doi.org/10.4103/2279-042X.122382

Arania, R., Triwahyuni, T., Esfandiari, F., & Nugraha, F. R. (2021). Hubungan antara usia, jenis kelamin, dan tingkat pendidikan dengan kejadian diabetes mellitus di Klinik Mardi Waluyo Lampung Tengah. Jurnal Medika Malahayati, 5(3), 146-153.

Aschalew, A. Y., Yitayal, M., & Minyihun, A. (2020). Health-related quality of life and associated factors among patients with diabetes mellitus at the University of Gondar referral hospital. Health and quality of life outcomes, 18(1), 1-8. https://doi.org/10.1186/s12955-020-01311-5

Astuty, A. D., Achmad, G. N. V., Nita, Y., Lestiono. (2020). Cost of Illness pada Pasien Diabetes Melitus dengan Diabetic Foot: Systematic Review. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 20-30

Etika, T. (2020). Analisis Cost of Illness Pada Pasien Hipertensi Peserta BPJS Rawat Jalan di Puskesmas Banyuanyar. Pharmaceutical Journal of Indonesia, 6(1), 41-46. https://doi.org/10.21776/ub.pji.2020.006.01.7

González, E. L., Johansson, S., Wallander, M. A., & Rodríguez, L. A. (2009). Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. Journal of epidemiology and community health, 63(4), 332–336. https://doi.org/10.1136/jech.2008.080382

Hidayati, I. R., Oktaviana, A., & Pristianty, L. (2022). Cost of Illness Type 2 Diabetes Mellitus Outpatient BPJS on Malang City Health Center. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 9(1), 1-7.

IDF, (2015). IDF Diabetes Atlas, Seventh Edition. International Diabetes Federation. https://diabetesatlas.org/

Islam, Z., Rusdi, N. K., & Nurhasnah, N. (2017). ANALISIS PERBEDAAN PENGOBATAN DIABETES MELITUS TIPE II PADA PASIEN BPJS DAN PASIEN UMUM. Media Farmasi: Jurnal Ilmu Farmasi, 14(2), 151-161.

Kattel, V., Subedi, M., Agrawal, Y., Pall, Z., Rani, S., Upadhyaya, S., Lavaju, P., Sarraf, D., & Maskey, R. (2019). Cost of Illness Study of Regular Out Patient Department Diabetic in a Low Income Country: A Cross Sectional Study. Journal of Diabetes and Endocrinology Association of Nepal, 3(1), 16–25. https://doi.org/10.3126/jdean.v3i1.24060

Manuntung, A. (2018). ANALISIS KEYAKINAN DIRI PASIEN DIABETES MELLITUS TIPE 2 DALAM PENGELOLAAN DIABETES MELLITUS.Jurnal Kesehatan Manarang, 3(1). https://doi.org/10.33490/jkm.v3i1.32

Megawati, F., Suwantara, I. P. T., & Suryani, N. L. S. A. (2020). PERBANDINGAN TARIF BIAYA PASIEN DIABETES MELLITUS RAWAT INAP UMUM DAN BPJS DI SALAH SATU RUMAH SAKIT UMUM DI DENPASAR PERIODE 2019. Jurnal Ilmiah Medicamento, 6(2). https://doi.org/10.36733/medicamento.v6i2.1028

Mongisidi, G. (2014). Hubungan antara status sosio-ekonomi dengan kejadian diabetes melitus tipe 2 di poliklinik interna BLU RSUP PROF. DR. RD Kandou Manado. Jurnal Fakultas Kesehatan Masyarakat Universitas Sam Ratulangi.

Mursalin, M., & Soewondo, P. (2017). Analisis Estimasi Biaya Langsung Medis Penderita Rawat Jalan Diabetes Mellitus Tipe 2 di RSUD Dr. Abdul Aziz Singkawang Tahun 2013. Jurnal Ekonomi Kesehatan Indonesia, 1(2). http://dx.doi.org/107454/eki.vli2.1770

Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012). Type 2 diabetes mellitus: a review of current trends. Oman medical journal, 27(4), 269–273. https://doi.org/10.5001/omj.2012.68

Pratiwi, A., Sukmawati, H., (2019). Analisis Biaya Rata-rata Pasien Rawat Inap dengan Penyakit Diabetes Melitus Tipe 2 (Studi di Jembarna dan Gianyar). Wicaksana: Jurnal Lingkungan dan Pembangunan 3, 21–29. https://doi.org/10.22225/wicaksana.3.2.2019.21-29

Pandey, A. R., Aryal, K. K., Shrestha, N., Sharma, D., Maskey, J., & Dhimal, M. (2022). Burden of diabetes mellitus in nepal: an analysis of global burden of disease study 2019. Journal of Diabetes Research, 2022. https://doi.org/10.1155/2022/4701796

Ramadhani, J., Erlianti, K., & Hasniah, H. (2021). ANALISIS COST OF ILLNESS PENYAKIT HIPERTENSI DI RUMAH SAKIT UMUM DAERAH PRAYA, NTB. AL ULUM: JURNAL SAINS DAN TEKNOLOGI, 6(2), 104-111. http://dx.doi.org/10.31602/ajst.v6i2.5226

Sari, L. (2017). Analisis Biaya Akibat Sakit serta Kualitas Hidup Pasien Diabetes Mellitus Tipe 2 dengan Penyakit Jantung. Jurnal Ekonomi Kesehatan Indonesia, 1(3). http://dx.doi.org/10.7454/eki.vli3.1777

Setiani, S., Rimba, I. R., & Dwinta, E. (2021). Analisis Perbandingan Biaya Perawatan (Cost of illness Stroke Iskemik dan Stroke Hemoragik Pasien Rawat Inap di SUD Pannembahan Senopati. Pharmaceutical Journal of Indonesia, 7(1), 29-36. https://doi.org/10.21776/ub.pji.2021.007.01.5

Setyaningrum, Z., Zulaekah, S., Rahmawaty, S., & Kurnia, P. (2022). EDUKASI KIAT JITU KONSUMSI MAKAN UNTUK MENGONTROL GLUKOSA DARAH PENDERITA DIABETES MELLITUS DI MASA PANDEMI. ALTAFANI: Jurnal Pengabdian Masyarakat, 1(1), 23-28.

Wardani, A., Witcahyo, E., & Utami, S. (2018). Efektivitas Biaya Program Pengelolaan Penyakit Kronis (Prolanis) di Puskesmas. HIGEIA (Journal of Public Health Research and Development), 2(4), 622-633. https://doi.org/10.15294/higeia.v2i4.20763

Warnaya, C., Larasanty, L., Meryta, L., Divacandraningrat, I., Iswari, W., Deviyanthi, I., & Sarasmita, M. (2020). Efektivitas Dan Biaya Pada Terapi Pasien Diabetes Mellitus Tipe 2 Rawat Jalan Di Rumah Sakit Umum Denpasar. Jurnal Farmasi Udayana, , 19-25. https://doi.org/10.24843/JFU.2020.v09.i01.p03


Article Statistic

Abstract view : 536 times
PDF (Bahasa Indonesia) views : 692 times

Dimensions Metrics

How To Cite This :

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.